Leveraging the advantage of single-cell sequencing techniques, here, we have established a machine learning framework utilizing the global expression profiles of major immune cells in the peripheral blood, derived from the CD45+ scRNA-seq data, to infer the immune status of the TME in patients with HNSCC (Fig. 1D). This evidence concerns the gene PTPRC and head and neck squamous cell carcinoma.